Marktanalyse - Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018


Summary


GlobalData’s new report, 'Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global biopsy devices market. The report provides market landscape, competitive landscape and market trends information on the biopsy devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.


Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Annualized market revenue data for 2011 and forecast forward for seven years to 2018. Company shares data for 2011.
- Qualitative analysis of key market trends, market drivers, and restraints within biopsy devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include C.R. BARD, Devicor Medical Products, CareFusion Corporation and Hologic.


Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the biopsy devices globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next big thing in the biopsy devices market landscape? — Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global biopsy devices market and the factors shaping it.


Press Release:

Cancer Scares in the Retired Population Boost the Biopsy Market

Government initiatives to raise awareness of cancer screenings in the increasing elderly population have resulted in the mass uptake of biopsy procedures, according to a new report by medical intelligence company GlobalData.

The new report* suggests that the medical devices market will encounter massive demand for screening equipment as doctors conduct ever-increasing numbers of biopsies, while concern for patient comfort will inspire less invasive screening technologies.

The increasingly elderly population has led to a higher prevalence of cancer, as the incidence rate of cancer rises in accordance with population age, spurring governments around the world to increase funding in raising awareness through the media. The United Nations’ State of the World Population 2011 report states that the global elderly population is growing at a rate of 2.6% per year, whereas the overall global population is increasing by only 1.1%. Therefore, cancer incidence and prevalence is anticipated to rise, which will in turn drive the future growth of the biopsy devices market.

Growing awareness of the importance of early cancer detection has led to high screening rates, which also acts to drive the biopsy devices market, as physicians rely on biopsies when other screening procedures do not prove conclusive.

The National Health Interview Survey in 2008 showed that 67% of women in the US aged 40 years and above had experienced a mammogram, compared to 29% in 1987. Similar increases in screening procedures for cervical cancer, colorectal cancer and prostate cancer have also been noted — a trend emerging not just in developed countries, but in developing countries too.

As increasing numbers of people are attending screenings, the quality of patient treatment is becoming an essential market factor, with desire mounting for minimally invasive ultrasound-guided vacuum-assisted biopsy devices, implying their future market domination over low-cost but less uncomfortable needle biopsies. Vacuum-assisted breast biopsy devices represent the fastest growing segment in the US market, and increased Medicare reimbursement given for such procedures is expected to help fuel demand.

The global biopsy devices market was valued at $970m in 2011, and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 5% to reach $1.4 billion by 2018. The US represents the largest national market, accounting for 50% of global revenue in 2011, and this market dominance is expected to continue to grow.

* Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

This report provides key data, information and analysis on the market landscape, competitive landscape and market trends information on the biopsy devices market. It provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 GlobalData Report Guidance 7

3 Disease Overview - Cancer 8

3.1 Epidemiology 8

4 Biopsy Devices - Overview 9

5 Biopsy Devices - Global Market Characterization 10

5.1 Biopsy Devices Market, Global, Revenue ($m), Forecast, 2011-2018 10

5.2 Biopsy Devices, Market Dynamics 11

5.2.1 Market Drivers 11

5.2.2 Market Restraints 15

6 Biopsy Devices Market, by Country, Revenue ($m), 2011-2018 16

6.1 Biopsy Devices Market, The US, Revenue ($m), 2011-2018 16

6.2 Biopsy Devices Market, Canada, Revenue ($m), 2011-2018 17

6.3 Biopsy Devices Market, The UK, Revenue ($m), 2011-2018 18

6.4 Biopsy Devices Market, Germany, Revenue ($m), 2011-2018 19

6.5 Biopsy Devices Market, France, Revenue ($m), 2011-2018 20

6.6 Biopsy Devices Market, Italy, Revenue ($m), 2011-2018 21

6.7 Biopsy Devices Market, Spain, Revenue ($m), 2011-2018 22

6.8 Biopsy Devices Market, Japan, Revenue ($m), 2011-2018 23

6.9 Biopsy Devices Market, China, Revenue ($m), 2011-2018 24

6.10 Biopsy Devices Market, India, Revenue ($m), 2011-2018 25

6.11 Biopsy Devices Market, Australia, Revenue ($m), 2011-2018 26

6.12 Biopsy Devices Market, Brazil, Revenue ($m), 2011-2018 27

7 Biopsy Devices Market: Strategic Competitive Assessment 28

7.1 Biopsy Devices Market, Global, Company Share (%), 2011 28

7.2 Biopsy Devices, Market Opportunities and Risk Evaluation 29

7.2.1 Opportunities 29

7.3 Biopsy Devices Market, Key Market Participants 30

7.3.1 C.R. Bard 30

7.3.2 Devicor Medical Products, Inc. 31

7.3.3 CareFusion Corporation 32

7.3.4 Hologic, Inc. 33

8 Biopsy Devices Market - Strategic Pipeline Assessment 35

8.1 Biopsy Devices, List Pipeline Products 37

8.2 Biopsy Devices, Key Pipeline Products 38

8.2.1 Aspire Biopsy: Control Medical Technology 38

8.2.2 Aspire Rotational Vacuum-Assisted Biopsy: Control Medical Technology 38

8.2.3 Biopsy Device: Precision Biopsy Llc 38

8.2.4 Endoarterial Biopsy Catheter: Vascular BioSciences 39

8.2.5 Endobronchial Lung Navigation and Biopsy System: Veran Medical Technologies, Inc. 39

8.2.6 Guideliner: Guide-X Ltd. 40

8.2.7 Hunter Biopsy Marker Device: Vascular Solutions, Inc. 40

8.2.8 Minimally Invasive Cutting Instrumentation: C.R. Bard, Inc. 40

8.2.9 Next Generation Fluorescence Based System: SpectraScience, Inc. 41

8.2.10 Radio Frequency Tissue Welding Device: VitruMed Inc. 41

8.2.11 Robopsy System: Robopsy 41

8.2.12 SnapPath Biomarker Testing System: BioMarker Strategies 42

8.2.13 Scobe-E System: Oncoscope, Inc. 42

8.2.14 Verisante Core: Verisante Technology, Inc. 43

8.2.15 Verisante Aura: Verisante Technology, Inc. 43

8.2.16 WavStat - Bladder Cancer: SpectraScience, Inc. 43

8.2.17 WavStat - Esophageal Cancer: SpectraScience, Inc. 44

8.2.18 WavStat - Gastric Cancer: SpectraScience, Inc. 44

8.2.19 WavStat - Inflammatory Bowel Syndrome: SpectraScience, Inc. 45

8.2.20 WavStat - Lung Cancer: SpectraScience, Inc. 45

8.2.21 WavStat - Pancreatic Cancer: SpectraScience, Inc. 45

8.2.22 WavStat - Skin Cancer: SpectraScience, Inc. 46

9 Biopsy Devices Market - Deals Landscape 47

9.1 Biopsy Devices Market, Key Deals, 2007—2011 47

9.1.1 Ums United Medical Acquires Mobile Biopsy, 2011 47

9.1.2 C. R. Bard Acquires SenoRx for $213m, 2010 48

9.1.3 C. R. Bard Acquires Assets from Inrad, 2007 48

9.1.4 iCAD Enters into Distribution Agreement with Hitachi Medical Systems, 2011 49

9.1.5 Abnova Enters into Co-Development Agreement with Clearbridge BioMedics, 2011 49

9.1.6 Ethicon Endo-Surgery Completes Sale of Breast Care Business to Devicor Medical Products, 2010 50

9.1.7 Varian Medical Systems Acquires Pan-Pacific Enterprises, 2007 51

9.1.8 Hologic Acquires Suros Surgical Systems, 2006 51

9.1.9 Hologic Sells Intellectual Property of Mammotest System to Siemens, 2006 52

10 Appendix 53

10.1 Definitions 53

10.1.1 Biopsy Devices 53

10.2 Acronyms 54

10.3 Sources 54

10.4 Research Methodology 55

10.4.1 Secondary Research 55

10.4.2 Primary Research 56

10.4.3 Models 56

10.4.4 Forecasts 56

10.4.5 Expert Panels 56

10.5 GlobalData Consulting 57

10.6 Contact Us 57

10.7 Disclaimer 57





1.1 List of Tables

Table 1: Biopsy Devices Market, Global, Revenue ($m), 2011-2018 10

Table 2: Leading Cancer Sites in the Lower Middle Income Economies, 2008 11

Table 3: Percentage of People Aged 65 Years and Above in Total Adult Population, by Country (%), 1980-2050 13

Table 4: National Average Medicare Payment Rate ($), The US, Vacuum-assisted Breast Biopsy vs. Core Needle Breast Biopsy, 2011 14

Table 5: Biopsy Devices Market, The US, Revenue ($m), 2011-2018 16

Table 6: Biopsy Devices Market, Canada, Revenue ($m), 2011-2018 17

Table 7: Biopsy Devices Market, The UK, Revenue ($m), 2011-2018 18

Table 8: Biopsy Devices Market, Germany, Revenue ($m), 2011-2018 19

Table 9: Biopsy Devices Market, France, Revenue ($m), 2011-2018 20

Table 10: Biopsy Devices Market, Italy, Revenue ($m), 2011-2018 21

Table 11: Biopsy Devices Market, Spain, Revenue ($m), 2011-2018 22

Table 12: Biopsy Devices Market, Japan, Revenue ($m), 2011-2018 23

Table 13: Biopsy Devices Market, China, Revenue ($m), 2011-2018 24

Table 14: Biopsy Devices Market, India, Revenue ($m), 2011-2018 25

Table 15: Biopsy Devices Market, Australia, Revenue ($m), 2011-2018 26

Table 16: Biopsy Devices Market, Brazil, Revenue ($m), 2011-2018 27

Table 17: Biopsy Devices Market, Global, Company Share (%), Revenue ($m), 2011 28

Table 18: C.R. Bard, Key Marketed Products 31

Table 19: Devicor Medical Products, Inc., Key Marketed Products 32

Table 20: CareFusion Corporation, Key Marketed Products 33

Table 21: Hologic, Inc., Key Marketed Products 34

Table 22: Biopsy Devices, List of Pipeline Products, 2012 37

Table 23: Aspire Biopsy, Product Status, 2011 38

Table 24: Aspire Rotational Vacuum-Assisted Biopsy, Product Status, 2011 38

Table 25: Biopsy Device, Product Status, 2011 39

Table 26: Endoarterial Biopsy Catheter, Product Status, 2011 39

Table 27: Endobronchial Lung Navigation and Biopsy System, Product Status, 2011 39

Table 28: Guideliner, Product Status, 2011 40

Table 29: Hunter Biopsy Marker Device, Product Status, 2011 40

Table 30: Minimally Invasive Cutting Instrumentation, Product Status, 2011 40

Table 31: Next Generation Fluorescence Based System, Product Status, 2011 41

Table 32: Radio Frequency Tissue Welding Device, Product Status, 2011 41

Table 33: Robopsy System, Product Status, 2011 41

Table 34: SnapPath Biomarker Testing System, Product Status, 2011 42

Table 35: Scobe-E System, Product Status, 2011 42

Table 36: Verisante Core, Product Status, 2011 43

Table 37: Verisante Aura, Product Status, 2011 43

Table 38: WavStat - Bladder Cancer, Product Status, 2011 44

Table 39: WavStat - Esophageal Cancer, Product Status, 2011 44

Table 40: WavStat - Gastric Cancer, Product Status, 2011 44

Table 41: WavStat - Inflammatory Bowel Syndrome, Product Status, 2011 45

Table 42: WavStat - Lung Cancer, Product Status, 2011 45

Table 43: WavStat - Pancreatic Cancer, Product Status, 2011 46

Table 44: WavStat - Skin Cancer, Product Status, 2011 46

Table 45: Biopsy Devices Market, Deals, by Volume, Global, 2006—2011* 47

Table 46: Ums United Medical Acquires Mobile Biopsy, 2011 47

Table 47: C. R. Bard Acquires SenoRx for $213m, 2010 48

Table 48: C. R. Bard Acquires Assets from Inrad, 2007 48

Table 49: iCAD Enters into Distribution Agreement with Hitachi Medical Systems, 2011 49

Table 50: iCAD Enters into Distribution Agreement with Hitachi Medical Systems, 2011 49

Table 51: Ethicon Endo-Surgery Completes Sale of Breast Care Business to Devicor Medical Products, 2010 50

Table 52: Varian Medical Systems Acquires Pan-Pacific Enterprises, 2007 51

Table 53: Hologic Acquires Suros Surgical Systems, 2006 51

Table 54: Hologic Sells Intellectual Property of Mammotest System to Siemens, 2006 52





1.2 List of Figures

Figure 1: Biopsy Devices Market, Global, Revenue ($m), 2011-2018 10

Figure 2: Biopsy Devices, Market Dynamics 11

Figure 3: Percentage of People Aged 65 Years and Above in Total Adult Population, by Country (%), 1980-2050 12

Figure 4: Biopsy Devices Market, Needle Biopsy vs. Open Biopsy 13

Figure 5: Biopsy Devices Market, The US, Revenue ($m), 2011-2018 16

Figure 6: Biopsy Devices Market, Canada, Revenue ($m), 2011-2018 17

Figure 7: Biopsy Devices Market, The UK, Revenue ($m), 2011-2018 18

Figure 8: Biopsy Devices Market, Germany, Revenue ($m), 2011-2018 19

Figure 9: Biopsy Devices Market, France, Revenue ($m), 2011-2018 20

Figure 10: Biopsy Devices Market, Italy, Revenue ($m), 2011-2018 21

Figure 11: Biopsy Devices Market, Spain, Revenue ($m), 2011-2018 22

Figure 12: Biopsy Devices Market, Japan, Revenue ($m), 2011-2018 23

Figure 13: Biopsy Devices Market, China, Revenue ($m), 2011-2018 24

Figure 14: Biopsy Devices Market, India, Revenue ($m), 2011-2018 25

Figure 15: Biopsy Devices Market, Australia, Revenue ($m), 2011-2018 26

Figure 16: Biopsy Devices Market, Brazil, Revenue ($m), 2011-2018 27

Figure 17: Biopsy Devices Market, Global, Company Share (%), 2011 28

Figure 18: Biopsy Devices, Market Opportunities and Risk Evaluation, 2012 29

Figure 19: Biopsy Devices Market, Pipeline Assessment, by Development Stage 35

Figure 20: Biopsy Devices Market, Pipeline Assessment, by Unmet Need 36

• Ultrasound Systems Market to 2019 - Technological Advancements, Wide Applications and Device Portability to Drive Future Growth
• Global Atherectomy and Thrombectomy Devices Market 2012-2016
• Global Neurostimulation Devices Market 2012-2016
• Global Vascular Stents Market 2012-2016
• Injectable Drug Delivery Market by Formulations - Global Forecasts to 2017
• Medical Equipment Monthly Deals Analysis: March 2013- M&A and Investment Trends
• Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends – Q1 2013
• Remote Patient Monitoring Market to 2019 - Potential to Reduce Healthcare Cost Burden and Improve Quality of Care to Drive Future Growth
• Global Life Science and Chemical Instrumentation Market 2012-2016
• Global Refurbished Medical Equipment Market 2012-2016
• Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2012
• Medical Equipment Monthly Deals Analysis: February 2013 - M&A and Investment Trends
• MediPoint: Cardiac Assist Devices - APAC Analysis and Market Forecasts
• MediPoint: Cardiac Assist Devices - Current and Pipeline Products
• MediPoint: Cardiac Assist Devices - EU Analysis and Market Forecasts
• MediPoint: Cardiac Assist Devices - US Analysis and Market Forecasts
• Global ENT Devices Market 2012-2016
• Global ENT Devices Market 2012-2016
• Intraoperative Neuromonitoring Market in the US 2012-2016
• Medical Equipment Monthly Deals Analysis: January 2013- M&A and Investment Trends